Viral vector production for cell and gene therapies

UK businesses can apply for up to £16 million to grow manufacturing capacity for UK viral vector use in advanced therapy medicinal products.

This publication was withdrawn on

This competition is no longer open for applications. Search current funding opportunities.



To lead a project you must:

  • be a UK-based business of any size
  • manufacture viral vectors either:
    • to good manufacturing practice (GMP) standards as gene therapies
    • for viral transduction to generate gene-modified cell therapies

Please read the competition scope and guidance for applicants for this competition before you apply.

Published 23 October 2017